Aquestive Therapeutics
AQST
$2.87
Share price
-5.59%
Change (1 day)
-34.47%
Change (1 year)
Categories
Aquestive Therapeutics (AQST) - P/B ratio
P/B ratio as of April 2025 : -4.72
According to Aquestive Therapeutics
's latest financial reports the company has a price-to-book ratio of 4.92974.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aquestive Therapeutics - P/B ratio (from 2018 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | -5.34 | 321.25% |
| 2023-12-31 | -1.27 | 207.35% |
| 2022-12-31 | -0.4121 | -78.34% |
| 2021-12-31 | -1.90 | -48.71% |
| 2020-12-31 | -3.71 | -84.42% |
| 2019-12-31 | -23.8 | -252.72% |
| 2018-12-31 | 15.6 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 3.48 | -173.68% | 🇺🇸 USA |
 | 0.9118 | -119.33% | 🇺🇸 USA |